本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

193.95
+4.192.21%
盘后:192.00-1.9500-1.01%17:17 EDT
成交量:166.73万
成交额:3.20亿
市值:415.71亿
市盈率:-21.74
高:194.26
开:187.79
低:184.76
收:189.76
52周最高:224.31
52周最低:47.28
股本:2.14亿
流通股本:1.85亿
量比:0.74
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.95
市盈率(LYR):-32.60

数据加载中...

2026/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities